UCSD researchers said the device could benefit individuals who are managing both high blood pressure and diabetes, especially because they are at high risk of becoming seriously ill with COVID-19, according to the study published this month in Nature Biomedical Engineering.
“This type of wearable would be very helpful for people with underlying medical conditions to monitor their own health on a regular basis,” said Lu Yin, a nanoengineering PhD student at UCSD and co-first author of the study. “It would also serve as a great tool for remote patient monitoring, especially during the COVID-19 pandemic when people are minimizing in-person visits to the clinic.”
A single wearable skin patch that can perform multiple functions would also offer a convenient alternative for patients in intensive care units, including infants in the NICU, who require constant monitoring of their blood pressure and other signs.
More articles on digital transformation:
Cleveland Clinic building biorepository, plans to integrate it into innovation district
Anthem-backed digital health startup Sharecare to go public, hit $3.9B valuation
Kroger Health to launch smartphone COVID-19 rapid antigen at-home test kits
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.